Clinical trial CL1-95012-001
A first in human Phase 1/2 open-label, multicenter, dose escalation and expansion study of PRS-344/S095012 in patients with solid tumors
Organ | Multiple |
---|---|
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Servier |
EudraCT Identifier | 2019-003456-36 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05159388 |
Last update |